Sobĕslavský O
Bull World Health Organ. 1980;58(4):621-8.
A WHO collaborative study on viral hepatitis B in which 21 laboratories in 20 countries participated is described. The aim of the study was to define the prevalence of hepatitis B surface antigen (HBsAg), its subtypes, and its antibody (anti-HBs) by age and sex and urban or rural residence in normal populations in different parts of the world. High-risk groups in the populations and patients with various diseases were also investigated. The results of the study confirmed that HBsAg and anti-HBs prevalence rates were higher in African and Asian countries than in the Americas, Australia, and northern and central Europe. Some eastern and southern European countries, however, were also shown to have high HBsAg and anti-HBs prevalence rates, comparable with those in Africa and Asia. In countries with low HBsAg and anti-HBs prevalence, there seems to be a gradual build-up during late childhood or early adolescence, whereas in countries with high HBsAg and its antibody prevalence, they were frequently detected in preschool children. Although the trend was towards a higher frequency of HBsAg and anti-HBs in urban than in rural and in male than in female populations, the differences were in most cases not significant. On the other hand, a significantly higher prevalence of markers of hepatitis B virus infection was seen in high-risk population groups than in normal populations. This was, however, clearly defined only in areas with low HBsAg and anti-HBs prevalence in the normal population. The geographical distribution of HBsAg subtypes showed a higher prevalence of the ad subdeterminant over ay in central European countries, whereas in eastern and southern Europe the ay subtype predominated. In West Africa, ayw was the only variant found, whereas in East Africa ad occurred more frequently than ay. In Australia, both adw and ayw subtypes were detected, whereas in the Far East and South-east Asia only adw and adr were seen.
本文描述了一项由世界卫生组织开展的关于乙型病毒性肝炎的合作研究,来自20个国家的21个实验室参与其中。该研究旨在确定世界不同地区正常人群中乙肝表面抗原(HBsAg)及其亚型、抗体(抗-HBs)按年龄、性别以及城乡居住地划分的流行情况。同时还对人群中的高危群体和各类疾病患者进行了调查。研究结果证实,非洲和亚洲国家的HBsAg和抗-HBs流行率高于美洲、澳大利亚以及北欧和中欧国家。然而,一些东欧和南欧国家也显示出较高的HBsAg和抗-HBs流行率,与非洲和亚洲国家相当。在HBsAg和抗-HBs流行率较低的国家,其流行率在儿童晚期或青春期早期似乎有逐渐上升的趋势,而在HBsAg及其抗体流行率较高的国家,学龄前儿童中经常检测到这些指标。尽管总体趋势是城市人群中HBsAg和抗-HBs的出现频率高于农村人群,男性高于女性,但在大多数情况下差异并不显著。另一方面,高危人群组中乙肝病毒感染标志物的流行率明显高于正常人群。不过,这一点仅在正常人群中HBsAg和抗-HBs流行率较低的地区有明确体现。HBsAg亚型的地理分布显示,中欧国家中ad亚决定簇的流行率高于ay,而在东欧和南欧,ay亚型占主导。在西非,ayw是唯一发现的变异型,而在东非,ad的出现频率高于ay。在澳大利亚,检测到了adw和ayw两种亚型,而在远东和东南亚地区仅发现了adw和adr。